Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000816971 | SCV000957503 | pathogenic | Aicardi-Goutieres syndrome 5 | 2023-07-18 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 659887). This premature translational stop signal has been observed in individual(s) with Aicardi-Goutièressyndrome (PMID: 24183309). This variant is present in population databases (rs768409471, gnomAD 0.002%). This sequence change creates a premature translational stop signal (p.Lys492Asnfs*2) in the SAMHD1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SAMHD1 are known to be pathogenic (PMID: 19525956, 22461318). |
Fulgent Genetics, |
RCV002495159 | SCV002779992 | likely pathogenic | Aicardi-Goutieres syndrome 5; Chilblain lupus 2 | 2022-05-11 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001830789 | SCV002090974 | pathogenic | Aicardi Goutieres syndrome | 2020-08-15 | no assertion criteria provided | clinical testing |